ArticlePlant communications2026
Myosin VIII and XI isoforms interact with the Agrobacterium VirE2 protein and facilitate its transport from the plasma membrane to the perinuclear region during plant transformation.
Article in Plant communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- A grass-specific structural myosin VIII regulates protoxylem development and hydraulic conductance in sorghum.Plant physiology · 2026Article
- The class VIII myosin ATM2 stabilizes actin-plasma membrane contacts in tobacco pollen tubes by locally promoting PtdIns(4,5)PNature plants · 2026Article
- The calmodulin-like proteins, CML13 and CML14 function as myosin light chains for the class XI myosins in Arabidopsis.Plant & cell physiology · 2026Article
- Functional characterization of calmodulin-like proteins, CML13 and CML14, as novel light chains of Arabidopsis class VIII myosins.Journal of experimental botany · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Agrobacterium transfers single-stranded T-DNA (T-strands) and virulence effector proteins into plant cells. VirE2, a key effector protein, enters the plant cell and is thought to bind T-strands, protecting them from nuclease degradation and guiding them to the nucleus. However, the intracellular trafficking mechanisms of VirE2 remain unclear. Using bimolecular fluorescence complementation, in vitro pull-down, yeast two-hybrid, and in vivo co-immunoprecipitation assays, we found that VirE2 binds directly to the cargo-binding domains (CBDs) of several myosin VIII family members and to myosin XI-K. We observed reduced susceptibility to Agrobacterium-mediated transformation of several Arabidopsis actin mutants and in a myosin VIII-1/2/a/b quadruple mutant. Expression of the CBDs of myosin VIII-1, VIII-2, VIII-A, or VIII-B in transgenic plants will inhibit Arabidopsis root transformation. However, none of the myosin VIII proteins contributes to the intracellular trafficking of VirE2. Expression of myosin VIII-2, VIII-A, and VIII-B, but not VIII-1, cDNAs in the myosin VIII-1/2/a/b mutant can partially restore transformation efficiency. Furthermore, functional fluorescent protein-tagged VirE2 synthesized in plant cells relocalizes from the cell periphery to the cytoplasm following T-strand delivery from Agrobacterium. Surprisingly, an Arabidopsis myosin XI-k mutant, transgenic plants expressing the myosin XI-K CBD, and plants subjected to RNAi targeting myosin XI-k all remain highly transformable, even though VirE2 movement along actin filaments is blocked. We hypothesize that myosin VIII proteins facilitate VirE2 tethering to the plasma membrane and are required for its efficient localization to membrane sites where it binds incoming T-strands, whereas myosin XI-K is important for VirE2 movement through the cytoplasm toward the nucleus.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.